This inventor holds 1 USPTO granted patent. Top assignee: National Research Council of Canada. Active years: 2007.
Company Filing History:
Years Active: 2007
Title: Laura M McIntosh: Innovator in Non-Invasive Skin Disease Screening
Introduction
Laura M McIntosh is a prominent inventor based in St. Laurent, Canada. She has made significant contributions to the field of dermatology through her innovative research and development of non-invasive diagnostic tools. Her work focuses on utilizing visible and near-infrared spectroscopy to enhance the diagnosis of skin diseases.
Latest Patents
Laura holds a patent for her invention titled "Non-invasive screening of skin diseases by visible/near-infrared spectroscopy." This groundbreaking tool aims to provide a non-invasive method for diagnosing skin diseases, which could serve as a valuable clinical adjunct. The study involved collecting in-vivo visible and near-infrared spectra of various skin neoplasms, including actinic keratoses and basal cell carcinomata, using a fiber optic probe. The results demonstrated significant spectral differences between normal skin and skin lesions, indicating the potential of this technique for accurate classification of skin conditions.
Career Highlights
Laura is affiliated with the National Research Council of Canada, where she continues to advance her research in skin disease diagnostics. Her innovative approach has garnered attention in the medical community, highlighting the importance of non-invasive techniques in clinical practice.
Collaborations
Laura has collaborated with notable colleagues, including Michael Jackson and Henry Mantsch, Ii. These partnerships have contributed to the depth and breadth of her research, fostering an environment of innovation and discovery.
Conclusion
Laura M McIntosh is a trailblazer in the field of non-invasive skin disease screening. Her patent and ongoing research reflect her commitment to improving diagnostic methods in dermatology. Through her work, she is paving the way for advancements that could significantly impact patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile